Stay updated on KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Results have been posted for the study, including primary and secondary outcomes (PFS, response rate, and overall survival) and related time frames. Updated study dates reflect the start date, primary completion date, and study completion date.
    Difference
    0.4%
    Check dated 2025-11-03T01:30:12.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-05T10:23:31.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:22:04.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing the old v3.0.1, and the 'Back to Top' link has been removed.
    Difference
    0.2%
    Check dated 2025-09-13T17:37:27.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T15:02:42.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as updates to related medical topics. However, several important drug information and genetic resources have been removed.
    Difference
    2%
    Check dated 2025-08-30T11:48:53.000Z thumbnail image

Stay in the know with updates to KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page.